Patents by Inventor Kyung-A Kim

Kyung-A Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240402182
    Abstract: Provided are: a peptide targeting Fusobacteria, comprising a peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 77 to 83; a composition for diagnosing cancer, comprising same; and a drug delivery composition. The peptide targeting Fusobacteria accurately targets Fusobacteria, which are harmful bacteria in various diseases, including cancer, and thus can be effectively used in cancer diagnosis and drug delivery.
    Type: Application
    Filed: October 11, 2022
    Publication date: December 5, 2024
    Applicant: INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY
    Inventors: Han Sang KIM, Kyung-A KIM, Joong Bae AHN, Soon Myung PAIK, Dong Eun YONG, Hyukmin LEE
  • Patent number: 9682113
    Abstract: Disclosed is a method for preventing, improving and/or treating cornea damage or a corneal disease, including administering an effective amount of an extract of a persimmon tree for preventing, improving or treating cornea damage to a subject in need thereof. The extract may be a persimmon leaf extract and the extract is effective in suppressing inflammation of the cornea and protecting corneal cells.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: June 20, 2017
    Assignee: Korea Institute of Science and Technology
    Inventors: Sang Hoon Jung, Kyung A Kim, Suk-Woo Kang, Joo Young Lee, Hong Ryul Ahn, Youngwoo Song
  • Publication number: 20160310551
    Abstract: Disclosed is a method for preventing, improving and/or treating cornea damage or a corneal disease, including administering an effective amount of an extract of a persimmon tree for preventing, improving or treating cornea damage to a subject in need thereof. The extract may be a persimmon leaf extract and the extract is effective in suppressing inflammation of the cornea and protecting corneal cells.
    Type: Application
    Filed: April 19, 2016
    Publication date: October 27, 2016
    Applicant: Korea Institute of Science and Technology
    Inventors: Sang Hoon JUNG, Kyung A KIM, Suk-Woo KANG, Joo Young LEE, Hong Ryul AHN, Youngwoo SONG
  • Patent number: 8242094
    Abstract: The present invention relates to a siRNA which targets mRNA of the NF-Kappa B p105 gene to cause its degradation by RNAi induction. In addition, the present invention provides a pharmaceutical composition for the treatment of diseases associated with aberrant cell proliferation and migration, comprising the siRNA and delivery vehicle capable of intracellular delivery of the same.
    Type: Grant
    Filed: August 22, 2008
    Date of Patent: August 14, 2012
    Assignee: Biopolymed, Inc.
    Inventors: Myung-Ok Park, Choun-Ki Joo, Jun-Sub Choi, Kyung-A Kim, Sung-Sik Bang
  • Publication number: 20110280929
    Abstract: The present invention relates to a siRNA which targets mRNA of the NF-Kappa B p105 gene to cause its degradation by RNAi induction. In addition, the present invention provides a pharmaceutical composition for the treatment of diseases associated with aberrant cell proliferation and migration, comprising the siRNA and delivery vehicle capable of intracellular delivery of the same.
    Type: Application
    Filed: August 22, 2008
    Publication date: November 17, 2011
    Inventors: Myung-Ok Park, Choun-Ki Joo, Jun-Sub Choi, Kyung-A Kim, Sung-Sik Bang